The FDA has cleared Ultherapy PRIME, Merz's microfocused ultrasound (MFU) device, for skin laxity on the knees. The clearance expands the platform beyond facial and neck applications into a high-demand body-sculpting zone—knees rank among the top aesthetic concerns for patients seeking non-invasive tightening without downtime.